Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McLaughlin

Showing results (471-480 of 1,494) with videos related to

Pageof 150
Sort By:
Archives of Pediatrics & Adolescent Medicine|May 3, 2006
Patterns and knowledge of nonmedical use of stimulants among college studentsBronwen C Carroll, Thomas J McLaughlin, Diane R Blake
Life Sciences|March 6, 1998
Naltrexone is not detected in preweaning rats following transplacental exposure: implications for growth modulationI S Zagon, W J Hurst, P J McLaughlin
Progress in Clinical and Biological Research|January 1, 1987
Identification of mannose 6-phosphate and mannose receptors in dystrophic and normal retinal pigment epitheliumB J McLaughlin, B I Tarnowski, V L Shepherd
Investigative Ophthalmology & Visual Science|February 1, 1988
Mannose 6-phosphate receptors on the plasma membrane on rat retinal pigment epithelial cellsB I Tarnowski, V L Shepherd, B J McLaughlin
Behavioral Neuroscience|October 5, 2001
Posttraining lesions of the medial prefrontal cortex impair performance of Pavlovian eyeblink conditioning but have no effect on concomitant heart rate changes in rabbits (Oryctolagus cuniculus)D A Powell, H Skaggs, J Churchwell, et al.
Current Physical Medicine and Rehabilitation Reports|October 4, 2019
Examining the role of precision medicine with oral baclofen in pediatric patients with cerebral palsyMatthew J McLaughlin, Susan Abdel-Rahman, J Steven Leeder
Head & Neck|May 18, 2011
Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neckPatricia J McLaughlin, Jaimon K Stucki, Ian S Zagon
Brain Research|March 19, 1990
Demonstration and characterization of zeta (zeta), a growth-related opioid receptor, in a neuroblastoma cell lineI S Zagon, S R Goodman, P J McLaughlin
Brain Research|July 16, 1990
Adult and developing human cerebella exhibit different profiles of opioid binding sitesI S Zagon, D M Gibo, P J McLaughlin
Brain Research|January 25, 2011
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosisKristen A Rahn, Patricia J McLaughlin, Ian S Zagon
Pageof 150

Showing results (471-480 of 1,494) with videos related to

Sort By:
Pageof 150
Archives of Pediatrics & Adolescent Medicine|May 3, 2006
Patterns and knowledge of nonmedical use of stimulants among college studentsBronwen C Carroll, Thomas J McLaughlin, Diane R Blake
Life Sciences|March 6, 1998
Naltrexone is not detected in preweaning rats following transplacental exposure: implications for growth modulationI S Zagon, W J Hurst, P J McLaughlin
Progress in Clinical and Biological Research|January 1, 1987
Identification of mannose 6-phosphate and mannose receptors in dystrophic and normal retinal pigment epitheliumB J McLaughlin, B I Tarnowski, V L Shepherd
Investigative Ophthalmology & Visual Science|February 1, 1988
Mannose 6-phosphate receptors on the plasma membrane on rat retinal pigment epithelial cellsB I Tarnowski, V L Shepherd, B J McLaughlin
Behavioral Neuroscience|October 5, 2001
Posttraining lesions of the medial prefrontal cortex impair performance of Pavlovian eyeblink conditioning but have no effect on concomitant heart rate changes in rabbits (Oryctolagus cuniculus)D A Powell, H Skaggs, J Churchwell, et al.
Current Physical Medicine and Rehabilitation Reports|October 4, 2019
Examining the role of precision medicine with oral baclofen in pediatric patients with cerebral palsyMatthew J McLaughlin, Susan Abdel-Rahman, J Steven Leeder
Head & Neck|May 18, 2011
Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neckPatricia J McLaughlin, Jaimon K Stucki, Ian S Zagon
Brain Research|March 19, 1990
Demonstration and characterization of zeta (zeta), a growth-related opioid receptor, in a neuroblastoma cell lineI S Zagon, S R Goodman, P J McLaughlin
Brain Research|July 16, 1990
Adult and developing human cerebella exhibit different profiles of opioid binding sitesI S Zagon, D M Gibo, P J McLaughlin
Brain Research|January 25, 2011
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosisKristen A Rahn, Patricia J McLaughlin, Ian S Zagon
Pageof 150